Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy

Nephrology Dialysis Transplantation

Volumn 16, Issue 11, 2001, Pages 2181-2187

  Canaud, Bernard ^a   Wizemann, Volker ^b   Pizzarelli, Francesco ^c   Greenwood, Roger ^d   Schultze, Georg ^e   Weber, Christoph ^f   Falkenhagen, Dieter ^g  

^a LAPEYRONIE HOSPITAL   (France)

^b Georg Haas Dialysis Centre   (Germany)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d LISTER HOSPITAL   (United Kingdom)

^e Dialysis Center Villingen Schwenningen   (Germany)

^f FRESENIUS MEDICAL CARE   (Germany)

^g DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

Chronic inflammation; Cytokine inducing substances; Endotoxins; Interleukin 1 receptor antagonist; On line haemodiafiltration

Indexed keywords

CYTOKINE; DIALYSIS FLUID; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; PYROGEN;

ADULT; AGED; ARTICLE; BACTERIAL COUNT; BACTERIUM CONTAMINATION; CLINICAL ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; COMPLICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIALYSATE; EXPOSURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INFLAMMATION; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; MICROBIOLOGICAL PARAMETERS; ONLINE SYSTEM; PRIORITY JOURNAL; SAFETY; SUPERNATANT;

EID: 0035158893     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.11.2181     Document Type: Article

References (34)

1. Long-term morbidity: Hemofiltration vs. hemodialysis
2. Convective treatments with on-line production of replacement fluid: A clinical experience lasting 6 years
3. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments
4. Microbial and endotoxin contamination in water and dialysate in the central United States
5. Microbiological quality of water and dialysate in all hemodialysis centres of Greece
6. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and Limulus amebocyte lysate methods
7. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood
8. Endotoxins modulate chronically tumour necrosis factor alpha and interleukin 6 release by uraemic monocytes
9. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis
10. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients
11. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients
12. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
13. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
14. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
15. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
16. Immunologic function and survival in hemodialysis patients
17. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients
18. A novel on-line infusate-assisted dialysis system performs microbiologically safely
19. In vitro production of interleukin-1 receptor antagonist in chronic renal failure. CAPD and HD
20. The differential production of three forms of IL-1 receptor antagonists by human neutrophils and monocytes
21. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β
22. Interleukin-1β (IL-1β), IL-1 receptor antagonists and TNFα production in whole blood
23. Production of interleukin-1-receptor antagonist during experimental endotoxaemia
24. Cytokine induction in patients undergoing regular on-line hemodia-filtration treatment
25. Interleukin-1 receptor antagonist: An index of dialysis-induced interleukin-1 production
26. Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumor necrosis factor α by circulating monocytes
27. Balance between IL-1β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis
28. Whole blood production of monocytic cytokines (IL-1β, IL-6, TNF-α, sIL-6R, IL-1Ra) in haemodialysed patients
29. Interleukin-1 receptors and receptor antagonist in haemodialysis
30. Cytokine production in haemodiafiltration: A multicentre study
31. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes
32. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Translational signal provided by lipopolysaccharide or IL-1 itself
33. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells
34. Gene expression for interleukin-1β during hemodialysis